Fatal Outcomes in Family Transmission of Mycoplasma pneumoniaeCLINICAL INFECTIOUS DISEASESIF7.32011-11-0360OAAI
Synthesis and Distribution of CARDS Toxin During Mycoplasma pneumoniae Infection in a Murine ModelJOURNAL OF INFECTIOUS DISEASESIF4.52011-09-2850OAAI
Efficacy of increasing dosages of clarithromycin for treatment of experimental Mycoplasma pneumoniae pneumoniaJOURNAL OF ANTIMICROBIAL CHEMOTHERAPYIF3.62011-07-2517OAAI
Variation in Colonization, ADP-Ribosylating and Vacuolating Cytotoxin, and Pulmonary Disease Severity among Mycoplasma pneumoniae StrainsAMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINEIF19.42010-09-1562OAAI
Tigecycline Therapy Significantly Reduces the Concentrations of Inflammatory Pulmonary Cytokines and Chemokines in a Murine Model of Mycoplasma pneumoniae PneumoniaANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52009-04-0139OAAI
The impact of steroids given with macrolide therapy on experimental Mycoplasma pneumoniae respiratory infectionJOURNAL OF INFECTIOUS DISEASESIF4.52008-10-1578OAAI
Prospective randomized trial of empiric therapy with trimethoprim-sulfamethoxazole or doxycycline for outpatient skin and soft tissue infections in an area of high prevalence of methicillin-resistant Staphylococcus aureusANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52007-07-0187OAAI
Pneumonia and septicemia caused by Burkholderia thailandensis in the United StatesJOURNAL OF CLINICAL MICROBIOLOGYIF5.42006-12-01123OAAI
Evaluation of LBM415 (NVP PDF-713), a novel peptide deformylase inhibitor, for treatment of experimental Mycoplasma pneumoniae pneumoniaANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52005-10-0121OAAI
Microbiologic and immunologic evaluation of a single high dose of azithromycin for treatment of experimental Mycoplasma pneumoniae pneumoniaANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52005-09-0114OAAI
Mycoplasma pneumoniae induces host-dependent pulmonary inflammation and airway obstruction in mice肺炎支原体诱导小鼠宿主依赖性肺部炎症和气道阻塞AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGYIF5.32005-03-0166PREAI
IL-4-independent pathways exacerbate methacholine-induced airway hyperreactivity during mycoplasma respiratory diseaseJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22004-09-0115PRE
Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infectionANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52004-08-0132OAAI
Diagnostic utility and clinical significance of naso- and oropharyngeal samples used in a PCR assay to diagnose Mycoplasma pneumoniae infection in children with community-acquired pneumoniaJOURNAL OF CLINICAL MICROBIOLOGYIF5.42004-07-0152OAAI
Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in miceJOURNAL OF INFECTIOUS DISEASESIF4.52004-05-15163OAAI
Antimicrobial and immunologic activities of clarithromycin in a murine model of Mycoplasma pneumoniae-induced pneumoniaANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52003-05-0143OAAI
Garenoxacin (BMS-284756) and moxifloxacin in experimental meningitis caused by vancomycin-tolerant pneumococciANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52003-01-0120OAAI
A randomized, double-blind, placebo-controlled trial of dexamethasone in severe respiratory syncytial virus (RSV) infection: Effects on RSV quantity and clinical outcomeJOURNAL OF INFECTIOUS DISEASESIF4.52002-05-0197OAAI
BMS-284756 in experimental cephalosporin-resistant pneumococcal meningitisANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52001-11-0113OAAI
Pharmacodynamics and bactericidal activity of moxifloxacin in experimental Escherichia coli meningitisANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52001-11-0135OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向